相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heparanase is preferentially expressed in human psoriatic lesions and induces development of psoriasiform skin inflammation in mice
Immanuel Lerner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
The role of heparanase and the endothelial glycocalyx in the development of proteinuria
Marjolein Garsen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Macrophage Activation by Heparanase Is Mediated by TLR-2 and TLR-4 and Associates With Plaque Progression
Miry Blich et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Renal Protective Effects of Toll-like Receptor 4 Signaling Blockade in Type 2 Diabetic Mice
J. J. Cha et al.
ENDOCRINOLOGY (2013)
The heparanase/syndecan-1 axis in cancer: mechanisms and therapies
Vishnu C. Ramani et al.
FEBS JOURNAL (2013)
AGE-LDL Activates Toll Like Receptor 4 Pathway and Promotes Inflammatory Cytokines Production in Renal Tubular Epithelial Cells
Ao Cheng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Versatile role of heparanase in inflammation
Rachel Goldberg et al.
MATRIX BIOLOGY (2013)
Macrophages directly mediate diabetic renal injury
Hanning You et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
Natali Gil et al.
DIABETES (2012)
Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes
Andrew F. Ziolkowski et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Molecular Mechanisms Responsible for the Selective and Low-Grade Induction of Proinflammatory Mediators in Murine Macrophages by Lipopolysaccharide
Urmila Maitra et al.
JOURNAL OF IMMUNOLOGY (2012)
The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis
Eric P. Schmidt et al.
NATURE MEDICINE (2012)
Urinary heparanase activity in patients with Type 1 and Type 2 diabetes
Angelique L. W. M. M. Rops et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Inflammation in Diabetic Nephropathy
Andy K. H. Lim et al.
MEDIATORS OF INFLAMMATION (2012)
Sulodexide for Kidney Protection in Type 2 Diabetes Patients With Microalbuminuria: A Randomized Controlled Trial
Edmund J. Lewis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Regulation of heparanase by albumin and advanced glycation end products in proximal tubular cells
Valentina Masola et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Renato V. Iozzo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice
Immanuel Lerner et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
The Role of Heparanase in Diseases of the Glomeruli
Maciej Szymczak et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2010)
Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy
Chia-Chao Wu et al.
CLINICA CHIMICA ACTA (2010)
Endogenous toll-like receptor ligands and their biological significance
Li Yu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Diabetic kidney disease: act now or pay later
Robert C. Atkins et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2010)
Macrophages and Diabetic Nephropathy
Greg H. Tesch
SEMINARS IN NEPHROLOGY (2010)
Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies
Omar S. Al-Attas et al.
CARDIOVASCULAR DIABETOLOGY (2009)
Tumor necrosis factor-α as a therapeutic target for diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
NF-kappaB signalling in chronic kidney disease
Gopala Rangan et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix Metalloproteinases
Eyal Zcharia et al.
PLOS ONE (2009)
Advanced Glycation End-Product of Low Density Lipoprotein Activates the Toll-Like 4 Receptor Pathway Implications for Diabetic Atherosclerosis
Conrad P. Hodgkinson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Diabetic nephropathy: Important pathophysiologic mechanisms
G. Soldatos et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment
Ghada Abboud-Jarrous et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The role of inflammatory cytokines in diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Role of macrophages in complications of type 2 diabetes
G. H. Tesch
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Heparan sulphate proteoglycans fine-tune mammalian physiology
Joseph R. Bishop et al.
NATURE (2007)
Increased expression of heparanase in overt diabetic nephropathy
M. J. van den Hoven et al.
KIDNEY INTERNATIONAL (2006)
Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy
Holger Schmid et al.
DIABETES (2006)
Analysis of TLR4 polymorphic variants: New insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling
Prasad Rallabhandi et al.
JOURNAL OF IMMUNOLOGY (2006)
Macrophage accumulation in human progressive diabetic nephropathy
Duy Nguyen et al.
NEPHROLOGY (2006)
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Neta Ilan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Projecting the number of patients with end-stage renal disease in the United States to the year 2015
DT Gilbertson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells - A potential role in the pathogenesis of proteinuria in diabetic patients
JB Maxhimer et al.
DIABETES (2005)
Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase
G Abboud-Jarrous et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Conditional signaling by Toll-like receptor 4
GJ Brunn et al.
FASEB JOURNAL (2005)
Serum albumin induces iNOS expression and NO production in RAW 267.4 macrophages
M Poteser et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis
FY Chow et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury
F Chow et al.
KIDNEY INTERNATIONAL (2004)
Transdifferentiation of epithelial glomerular cells
J Bariéty et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells
N Shanmugam et al.
DIABETES (2003)
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4
GB Johnson et al.
JOURNAL OF IMMUNOLOGY (2002)
Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications
K Conde-Knape
DIABETES-METABOLISM RESEARCH AND REVIEWS (2001)
分享论文
